Patrick Trucchio from H.C. Wainwright highlighted the FDA's approval as a pivotal moment for both patients suffering from ATTR-CM and for the future growth of Alnylam. He noted the drug's promising ...

Avviso esplicito sui rischi: Il trading degli strumenti finanziari e/o di criptovalute comporta alti rischi, compreso quello di perdere in parte, o totalmente, l’importo dell’investimento, e potrebbe ...

HC Wainwright analyst P. Trucchio now expects that the company will post earnings per share of $0.43 for the year, down from their prior forecast of $0.46. HC Wainwright has a “Buy” rating and ...

HC Wainwright analyst P. Trucchio now anticipates that the company will post earnings per share of ($0.16) for the quarter, down from their previous forecast of ($0.15). HC Wainwright has a “Buy ...

EXCLUSIVE: J. Alphonse Nicholson (P-Valley) is set for a key recurring role in Lanterns, HBO’s drama series based on the Green Lantern DC comic. He joins leads Kyle Chandler and Aaron Pierre and ...

Ratings for Precision BioSciences DTIL were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table ...

Across the recent three months, 8 analysts have shared their insights on Sangamo Therapeutics (NASDAQ:SGMO), expressing a variety of opinions spanning from bullish to bearish. The following table ...

11 analysts have expressed a variety of opinions on Harmony Biosciences Hldgs (NASDAQ:HRMY) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below ...

Trucchio and Steven Catalano, were sentenced to prison. Gotti’s mafia life was profiled in a 2018 film starring John Travolta. Alite has admitted to roles in several homicides and upward of 40 ...

Luis Santos: Hello, everyone. Thank you so much for taking our questions. This is Luis in for Patrick Trucchio. I was wondering if you’re still waiting on any data for the Fabry program as you ...

Sangamo Therapeutics, with a market capitalization of $211.78 million, reported its earnings for Q4 2024, posting an EPS of -0.11, slightly missing the forecast of -0.10. Revenue came in at 7.55 ...